-
Mashup Score: 0Phase 2b data point to safety, efficacy of focal therapy in intermediate-risk prostate cancer - 3 year(s) ago
In a study presented at the 2021 AUA annual meeting, Behfar Ehdaie, MD, MPH, and colleagues assessed the efficacy of focal therapy in treating patients with grade group 2 or 3 prostate cancers.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 2Phase 2b data point to safety, efficacy of focal therapy in intermediate-risk prostate cancer - 3 year(s) ago
In a study presented at the 2021 AUA annual meeting, Behfar Ehdaie, MD, MPH, and colleagues assessed the efficacy of focal therapy in treating patients with grade group 2 or 3 prostate cancers.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Phase 2b data point to safety, efficacy of focal therapy in intermediate-risk prostate cancer - 3 year(s) ago
In a study presented at the 2021 AUA annual meeting, Behfar Ehdaie, MD, MPH, and colleagues assessed the efficacy of focal therapy in treating patients with grade group 2 or 3 prostate cancers.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Phase 2b data point to safety, efficacy of focal therapy in intermediate-risk prostate cancer - 3 year(s) ago
In a study presented at the 2021 AUA annual meeting, Behfar Ehdaie, MD, MPH, and colleagues assessed the efficacy of focal therapy in treating patients with grade group 2 or 3 prostate cancers.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Interest grows for focal therapy in treating prostate cancer - 3 year(s) ago
In this interview, Ardeshir (Art) Rastinehad, DO, discusses the current state of focal therapy in prostate cancer, the role of fusion biopsy in pushing the treatment forward, and what institutions looking to implement focal therapy should know.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 3Interest grows for focal therapy in treating prostate cancer - 3 year(s) ago
In this interview, Ardeshir (Art) Rastinehad, DO, discusses the current state of focal therapy in prostate cancer, the role of fusion biopsy in pushing the treatment forward, and what institutions looking to implement focal therapy should know.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 1Prostate Cancer Focus 2021 - 3 year(s) agoSource: cloud.3dissue.netCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Prostate Cancer Focus 2021 - 3 year(s) agoSource: cloud.3dissue.netCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 2Prostate Cancer Focus 2021 - 3 year(s) agoSource: cloud.3dissue.netCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Prostate Cancer Focus 2021 - 3 year(s) agoSource: cloud.3dissue.netCategories: Latest Headlines, UrologyTweet
Phase 2b data point to safety, efficacy of focal therapy in intermediate-risk prostate cancer https://t.co/0Zym8iUCuR #urology #urologist #pcsm #prostatecancer #focaltherapy #prostate